Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy.
about
Anovulatory Patients Demonstrate a Sharp Decline in LH Levels upon GnRH Antagonist Administration during IVF Cycles.Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol.Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocolIs a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.Association between follicular fluid levels of HMGB1 protein and outcomes in patients undergoing in vitro fertilization/intracytoplasmic sperm injection cycles.GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).Ovarian feedback, mechanism of action and possible clinical implications.Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study.IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review.Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients.Change, change, change: hormonal actions depend on changes in blood levels.GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT.Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles
P2860
Q33633416-AC3167EE-9380-414A-A796-91BA992A32BCQ34421570-26238CB0-ABA5-40E7-AFB7-FCC82688D6F4Q34607007-036EE991-5A43-46F4-A432-9F736189921EQ35123968-6A016789-92DA-4CEB-9D6A-1CD59755C2BAQ35754018-6436DB68-EE46-4EDA-8E42-FEFE2118B3F8Q36235804-9416DE85-4E39-4AD8-A100-42A17481ABB7Q36467616-CB4663CB-CF41-4DAD-9D46-A0B9D68C006EQ36970408-9F41B926-CB3A-4011-A4E6-C0D5497321D8Q37126409-AE1AFF6F-8CBD-470B-96CF-1BB3FFE059EEQ37303241-F4A2996C-8475-4CBC-B079-BC47C4B1D3EDQ46150318-56DE3F6B-DD22-4976-8253-F9387032A091Q46713984-C502116D-368C-486E-B235-0D6A46D53BB9Q48703957-388156F6-3F72-4FC5-A76B-E16024E95B4DQ55072129-DC2A2927-068E-41EA-B7F6-1769277C1EE2Q58740607-15E804D0-98A3-4CAB-9A38-CF190CF71639
P2860
Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Dose-finding study of daily Gn ...... terone for clinical pregnancy.
@en
Dose-finding study of daily Gn ...... terone for clinical pregnancy.
@nl
type
label
Dose-finding study of daily Gn ...... terone for clinical pregnancy.
@en
Dose-finding study of daily Gn ...... terone for clinical pregnancy.
@nl
prefLabel
Dose-finding study of daily Gn ...... terone for clinical pregnancy.
@en
Dose-finding study of daily Gn ...... terone for clinical pregnancy.
@nl
P2093
P2860
P356
P1433
P1476
Dose-finding study of daily Gn ...... terone for clinical pregnancy.
@en
P2093
Andre C D van Loenen
Cornelis B Lambalk
Joop Schoemaker
Joseph McDonnell
Judith A F Huirne
Peter G A Hompes
Roel Schats
Roy Homburg
P2860
P304
P356
10.1093/HUMREP/DEH601
P407
P577
2004-11-26T00:00:00Z